The Johnson & Johnson should
"preferentially" be given to the over-60s," health ministry
prevention chief Gianni Rezza said in a circular on Wednesday.
The circular recommended the same conditions of use for the J&J
jab as the AstraZeneca one.
ALL RIGHTS RESERVED © Copyright ANSA